-
Product Insights
Mycoses Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Mycoses Global Clinical Trials Review, H1, 2018" provides an overview of Mycoses clinical trials scenario. This report provides top line data relating to the clinical trials on Mycoses. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Neisseria meningitidis Infections Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neisseria meningitidis Infections Global Clinical Trials Review, H1, 2018" provides an overview of Neisseria meningitidis Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Neisseria meningitidis Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Human Immunodeficiency Virus (HIV): Competitive Landscape to 2026
Human immunodeficiency virus (HIV) is a retrovirus that impairs and destroys the host’s immune system, specifically targeting CD4 cells. Once an infected person has a CD4 cell count of less than 200 cells/μL, HIV has developed into acquired immunodeficiency syndrome (AIDS). This report provides an assessment of the pipeline, clinical, and commercial landscape of HIV. Overall, GlobalData expects new drug approvals to drive HIV market growth over the next decade (2016–2026).
-
Product Insights
Neisseria gonorrhoeae Infections - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Neisseria gonorrhoeae Infections - Global Clinical Trials Review, H2, 2020" provides an overview of Neisseria gonorrhoeae Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Neisseria gonorrhoeae Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type....
-
Product Insights
Rabies - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Rabies - Global Clinical Trials Review, H2, 2021" provides an overview of Rabies Clinical trials scenario. This report provides top line data relating to the clinical trials on Rabies . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Product Insights
Genital Herpes - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Genital Herpes - Global Clinical Trials Review, H2, 2021" provides an overview of Genital Herpes Clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Herpes . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Herpes Labialis (Oral Herpes) - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) - Global Clinical Trials Review, H2, 2021" provides an overview of Herpes Labialis (Oral Herpes) Clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Product Insights
Syphilis - Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Syphilis - Global Clinical Trials Review, H2, 2021" provides an overview of Syphilis Clinical trials scenario. This report provides top line data relating to the clinical trials on Syphilis . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...
-
Sector Analysis
Human Immunodeficiency Virus (HIV) Therapeutics - Global Drug Forecast and Market Analysis to 2029
The human immunodeficiency virus (HIV) therapeutics market was worth an estimated $22.9bn across the seven major markets (7MM*) in 2019. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 2%. Growth in the market will be driven by the entry of injectable therapies that can be administered intramuscularly or subcutaneously. HIV-infected patients are normally managed with oral therapies. One type of treatment regimen involves the administration of one tablet per day. These single-tablet regimens (STRs)...
-
Product Insights
Tetanus Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Tetanus Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Tetanus Clinical trials scenario. This report provides top line data relating to the clinical trials on Tetanus . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.